Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative Review - PubMed (original) (raw)
Review
Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative Review
Emily Reeve et al. Curr Clin Pharmacol. 2015.
Abstract
Older adults with dementia commonly have multiple chronic conditions that prompt clinicians to prescribe medications. While dementia is a life-limiting disease, progression from mild cognitive impairment to end stage dementia is a process that can occur over many years and may not take a predetermined course. Therefore aligning pharmacological treatment with changing goals of care can be challenging. The aim of this narrative review was to explore barriers to optimising prescribing and deprescribing (withdrawing) of medications as the goal of care shifts from prolonging life to optimising quality of life. Optimising pharmacological treatment to help people with dementia achieve their goals of care often requires deprescribing of medications that are inappropriate, as well as initiating appropriate medications. Medical practitioner, system, patient and carer related barriers to optimisation of medications in older adults with multiple morbidities have been identified including: inadequate guidelines, incomplete medical histories, lack of time, avoidance of negative consequences, established beliefs in the benefits and harms of medication use and others. Optimising prescribing for older people with dementia is further complicated by diminished decision making capacity, difficulties with comprehension and communication, increasing involvement of carers and difficulties establishing goals of care. Further research is required into the attitudes, beliefs and preferences of people with dementia and their carers regarding prescribing and deprescribing.
Similar articles
- Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study.
Reeve E, Low LF, Hilmer SN. Reeve E, et al. Br J Gen Pract. 2016 Aug;66(649):e552-60. doi: 10.3399/bjgp16X685669. Epub 2016 Jun 6. Br J Gen Pract. 2016. PMID: 27266865 Free PMC article. - Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.
Rochon PA, Petrovic M, Cherubini A, Onder G, O'Mahony D, Sternberg SA, Stall NM, Gurwitz JH. Rochon PA, et al. Lancet Healthy Longev. 2021 May;2(5):e290-e300. doi: 10.1016/S2666-7568(21)00054-4. Lancet Healthy Longev. 2021. PMID: 36098136 Review. - The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
Bayliss EA, Shetterly SM, Drace ML, Norton J, Green AR, Reeve E, Weffald LA, Wright L, Maciejewski ML, Sheehan OC, Wolff JL, Gleason KS, Kraus C, Maiyani M, Du Vall M, Boyd CM. Bayliss EA, et al. Trials. 2020 Jun 18;21(1):542. doi: 10.1186/s13063-020-04482-0. Trials. 2020. PMID: 32552857 Free PMC article. - Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.
Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin PJ, Chenoweth L, Gorman M, Quirke L, Bethune G, Hilmer SN. Reeve E, et al. Med J Aust. 2019 Mar;210(4):174-179. doi: 10.5694/mja2.50015. Epub 2019 Feb 16. Med J Aust. 2019. PMID: 30771226 - The value of deprescribing in older adults with dementia: a narrative review.
Sawan MJ, Moga DC, Ma MJ, Ng JC, Johnell K, Gnjidic D. Sawan MJ, et al. Expert Rev Clin Pharmacol. 2021 Nov;14(11):1367-1382. doi: 10.1080/17512433.2021.1961576. Epub 2021 Aug 19. Expert Rev Clin Pharmacol. 2021. PMID: 34311630 Review.
Cited by
- Medication appropriateness tool for co-morbid health conditions in dementia: consensus recommendations from a multidisciplinary expert panel.
Page AT, Potter K, Clifford R, McLachlan AJ, Etherton-Beer C. Page AT, et al. Intern Med J. 2016 Oct;46(10):1189-1197. doi: 10.1111/imj.13215. Intern Med J. 2016. PMID: 27527376 Free PMC article. - Patterns of High-Dose and Long-Term Proton Pump Inhibitor Use: A Cross-Sectional Study in Six South Australian Residential Aged Care Services.
Hendrix I, Page AT, Korhonen MJ, Bell JS, Tan ECK, Visvanathan R, Cooper T, Robson L, Sluggett JK. Hendrix I, et al. Drugs Real World Outcomes. 2019 Sep;6(3):105-113. doi: 10.1007/s40801-019-0157-1. Drugs Real World Outcomes. 2019. PMID: 31264165 Free PMC article. - Implementation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)© into home medicines review: a protocol for a cluster-randomised clinical trial in older adults.
Kouladjian O'Donnell L, Sawan M, Reeve E, Gnjidic D, Chen TF, Kelly PJ, Bell JS, Hilmer SN. Kouladjian O'Donnell L, et al. BMC Geriatr. 2020 Feb 12;20(1):51. doi: 10.1186/s12877-020-1442-2. BMC Geriatr. 2020. PMID: 32050899 Free PMC article. Clinical Trial. - The Ethics of Deprescribing in Older Adults.
Reeve E, Denig P, Hilmer SN, Ter Meulen R. Reeve E, et al. J Bioeth Inq. 2016 Dec;13(4):581-590. doi: 10.1007/s11673-016-9736-y. Epub 2016 Jul 14. J Bioeth Inq. 2016. PMID: 27416980 - Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed.
Reeve E, Bayliss EA, Shetterly S, Maiyani M, Gleason KS, Norton JD, Sheehan OC, Green AR, Maciejewski ML, Drace M, Sawyer J, Boyd CM. Reeve E, et al. Age Ageing. 2023 Jan 8;52(1):afac335. doi: 10.1093/ageing/afac335. Age Ageing. 2023. PMID: 36702513 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical